HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Tumor-derived mutated E-cadherin influences beta-catenin localization and increases susceptibility to actin cytoskeletal changes induced by pervanadate.

Abstract
E-cadherin participates in homophilic cell-to-cell adhesion and is localized to intercellular junctions of the adherens type. In the present study, we investigated the localization of adherens junction components in cells expressing mutant E-cadherin derivatives which had been previously cloned from diffuse-type gastric carcinoma. The mutations are in frame deletions of exons 8 or 9 and a point mutation in exon 8 and affect the extracellular domain of E-cadherin. Our findings indicate that E-cadherin mutated in exon 8 causes beta-catenin staining at lateral cell-to-cell contact sites and, in addition, abnormally located beta-catenin in the perinuclear region. Moreover, the various mutant E-cadherin derivatives increased the steady-state levels of alpha- and beta-catenin and were found in association with these catenins even after induction of tyrosine phosphorylation by pervanadate. Sustained pervanadate treatment led, however, to rounding-up of cells and induction of filopodia, changes which were first detectable in cells expressing E-cadherin mutated in exon 8. The deterioration of the cell contact was not accompanied with disassembly of the E-cadherin-catenin complex. Based on these observations, we propose a model whereby in the presence of mutant E-cadherin tyrosine phoshorylation of components of the cell adhesion complex triggers loss of cell-to-cell contact and actin cytoskeletal changes which are not caused by the disruption of the E-cadherin-catenin complex per se, but instead might be due to phosphorylation of other signaling molecules or activation of proteins involved in the regulation of the actin cytoskeleton.
AuthorsB Luber, S Candidus, G Handschuh, E Mentele, P Hutzler, S Feller, J Voss, H Höfler, K F Becker
JournalCell adhesion and communication (Cell Adhes Commun) Vol. 7 Issue 5 Pg. 391-408 (May 2000) ISSN: 1061-5385 [Print] Switzerland
PMID10830618 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Actins
  • CTNNA1 protein, human
  • CTNNB1 protein, human
  • CTNNB1 protein, mouse
  • Cadherins
  • Catenins
  • Cell Adhesion Molecules
  • Ctnna1 protein, mouse
  • Cytoskeletal Proteins
  • Desmoplakins
  • Enzyme Inhibitors
  • Phosphoproteins
  • Trans-Activators
  • alpha Catenin
  • beta Catenin
  • pervanadate
  • Vanadates
  • Tyrosine
  • Protein Tyrosine Phosphatases
  • Delta Catenin
Topics
  • Actin Cytoskeleton (metabolism)
  • Actins (drug effects, metabolism)
  • Animals
  • Cadherins (genetics, metabolism)
  • Catenins
  • Cell Adhesion Molecules (metabolism)
  • Cell Line
  • Cytoskeletal Proteins (metabolism)
  • Cytoskeleton (drug effects, metabolism)
  • Desmoplakins
  • Enzyme Inhibitors (pharmacology)
  • Humans
  • Mice
  • Mutation
  • Phosphoproteins (metabolism)
  • Phosphorylation
  • Protein Tyrosine Phosphatases (pharmacology)
  • Stomach Neoplasms (genetics)
  • Trans-Activators
  • Tumor Cells, Cultured
  • Tyrosine (metabolism)
  • Vanadates (pharmacology)
  • alpha Catenin
  • beta Catenin
  • Delta Catenin

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: